Change in the total number of shares and votes in Recipharm AB (publ)

In November 2014, the number of shares in Recipharm AB (publ) (“Recipharm”) has
increased by 3,500,000 shares of series B, corresponding to 3,500,000 votes. The
increase in the number of shares and votes results from a share issue in
connection with the acquisition of the Lisbon based CDMO Lusomedicameta
Sociedade Técnica Farmacêutica S.A. as announced on 13 November 2014.
As of 28 November 2014, the total number of shares in Recipharm amounts to
40,688,875, divided into 12,685,716 shares of series A and 28,003,159 shares of
series B. The total number of votes in Recipharm as of 28 November 2014 amounts
to 154,860,319.

This information is published in accordance with Chapter 4, Section 9 of the
Swedish Financial Instruments Trading Act (SFS 1991:980).

For further information please visit www.recipharm.com or contact:
Thomas Eldered, CEO, thomas.eldered@recipharm.com, telephone: +46 8 602 52 10
Björn Westberg, CFO, bjorn.westberg@recipharm.com, telephone: +46 8 602 46 20

This information is published in accordance with the Swedish Securities Market
Act, the Swedish Financial Instruments Trading Act and/or the regulations of
Nasdaq Stockholm. This information was submitted for publication on 28 November
2014, at 11:00 am CET.

About Recipharm
Recipharm is a leading CDMO (Contract Development and Manufacturing
Organisation) in the pharmaceutical industry based in Sweden employing some
2,100 employees. Recipharm offers manufacturing services of pharmaceuticals in
various dosage forms, production of clinical trial material including API and
pharmaceutical product development. Recipharm manufactures more than 400
different products to customers ranging from Big Pharma through to smaller
research- and development companies. Recipharm’s turnover is approximately SEK
3.2 billion and the Company operates development and manufacturing facilities in
Sweden, France, the UK, Germany, Spain, Italy and Portugal and is headquartered
in Jordbro, Sweden. The Recipharm B-share (RECI B) is listed on NASDAQ
Stockholm.

For more information on Recipharm and our services, please visit
www.recipharm.com (http://file:///C:/Users/Thomas/AppData/Local/Microsoft/Window
s 
/Temporary%20Internet%20Files/Content.Outlook/FZHEQOEB/visit%20www.recipharm.com
) 
.